Filing Flows

Filing Flows › Cytokinetics (CYTK) › How it makes money

How Cytokinetics (CYTK) makes money

Cytokinetics (CYTK) made $47.6M of revenue in the third quarter 2026 (Q3 2026), up 25-fold from a year earlier. Net Product Revenue brought in $44.5M (94%); Collaboration Revenues brought in $3.0M (6%).

Drawing the Sankey…

Cytokinetics revenue by segment, Q3 2026Cytokinetics revenue by segment, Q3 2026Net Product Revenue$44.5MCollaboration Revenues$3.0M
Cytokinetics: revenue by line, Q1 2026 to Q3 2026Cytokinetics: revenue by line, Q1 2026 to Q3 2026Net Product RevenueLicense and Milestone…Collaboration RevenuesNet Product Revenue: $44.5M latest$44.5MLicense and Milestone Revenues: $0 latestCollaboration Revenues: $3.0M latestQ1 2026Q2 2026Q3 2026
Net Product Revenue went from 25% of revenue in Q1 2026 to 94% in Q3 2026, the largest shift in the mix.
Cytokinetics revenue by quarterCytokinetics revenue by quarter$1.6MQ1 2025$66.8MQ2 2025$1.9MQ3 2025$17.8MQ4 2025$19.4MQ1 2026$28.6MQ2 2026$47.6MQ3 2026

Revenue by segment, Q3 2026

SegmentRevenueShareQ/QY/Y
Net Product Revenue$44.5M93.6%+76%—
Collaboration Revenues$3.0M6.4%-7%+58%

Where each dollar of revenue goes

LineQ3 2026% of revenue
Revenue$47.6M100.0%

Revenue, quarter by quarter

QuarterRevenueY/Y
Q3 2026$47.6M25×
Q2 2026$28.6M-57%
Q1 2026$19.4M12×
Q4 2025$17.8M+5%
Q3 2025$1.9M+318%
Q2 2025$66.8M268×
Q1 2025$1.6M+89%

From Cytokinetics' 10-Q filed Nov 4, 2026 (on EDGAR).

Questions

How does Cytokinetics make money?

Cytokinetics (CYTK) made $47.6M of revenue in the third quarter 2026 (Q3 2026), up 25-fold from a year earlier. Net Product Revenue brought in $44.5M (94%); Collaboration Revenues brought in $3.0M (6%).

What is Cytokinetics' biggest business?

Net Product Revenue: $44.5M in the third quarter 2026, 94% of revenue.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.